A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults

<p><strong>BACKGROUND:</strong> This phase I trial evaluated the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost, previously demonstrated to be protective in animal studies, in healthy UK adults.</p> <p><stron...

Full description

Bibliographic Details
Main Authors: Wilkie, M, Satti, I, Minhinnick, A, Harris, S, Riste, M, Ramon, R, Sheehan, S, Thomas, Z, Wright, D, Stockdale, L, Hamidi, A, O'Shea, M, Dwivedi, K, Behrens, H, Davenne, T, Morton, J, Vermaak, S, Lawrie, A, Moss, P, McShane, H
Format: Journal article
Language:English
Published: Elsevier 2019